Safety and Efficacy of Intravitreal Risuteganib for Non-Exudative AMD: A Multicenter, Phase 2a, Randomized, Clinical Trial

Boyer, DS; Gonzalez, VH; Kunimoto, DY; Maturi, RK; Roe, RH; Singer, MA; Xavier, S; Kornfield, JA; Kuppermann, BD; Quiroz-Mercado, H; Aubel, J; Karageozian, HL; Park, JY; Karageozian, VH; Karageozian, L; Sarayba, MA; Kaiser, PK

Boyer, DS (corresponding author), 9001 Wilshire Blvd,Suite 301, Beverly Hills, CA 90211 USA.

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021; 52 (6): 327

Abstract

BACKGROUND AND OBJECTIVE: To evaluate the safety and efficacy of 1.0 mg risuteganib in subjects with nonexudative age-related macular degeneration (AM......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索